Related Videos


Choose Language:
S.No
Video Title
Creator's Name
Video Duration
No. of Views
No. of Likes
No. of Dislikes
Date of Upload
Relevance From scale 1 - 5
Ease of Understanding for General Public
Correctness and Authenticity from Scale 1-5
Comments
Category
Date of video curation
1
Corona vaccines, efficacy, types, etc
Prof Kshitish K Acharya
23mins 24secs
275
27
1
2021 Jan 17
5
Easy
5
Simplified explaination of Covid-19 vaccines and the necessity for vaccination
Public health
2021 Jan 29
2
Reasons for varied responses to Corona. And, the best way to prevent deaths due to Covid19
Prof Kshitish K Acharya
9mins 06sec
437
55
-
2020 Oct 21
5
Easy
5
Dr. Kshitish explains in a simplified way why there is a varied response to SARS-CoV-2 infection
Public health
2021 Jan 29
3
Scientific information about corona virus: simple straight science part I (English
Prof Kshitish K Acharya
16mins 12secs
484
63
0
2020 Aug 15
5
Easy
5
Simplified explaintion about viruses in general and how they make their entry into the cell.
Basic science
2021 Apr 09
4
Ayurveda vs. Modern medicine: Simple Straight Science, part 2 [ENGLSIH]
Prof Kshitish K Acharya
15mins 19secs
309
50
0
2020 Aug 15
5
Easy
5
Dr.Kshitish Acharya talks about the basic difference between Ayurveda and Modern Medicine
Traditional medicin
2021 Apr 09
5
COVID and the ACE-2 surface protein
Doctor Klioze
13 min 19 secs
213K
4.1K
99
2020 May 03
5
OK
5
Introduction to ACE2
ACE2
2021 Jan 30
6
How to tell if we're beating COVID-19
minutephysics
7 mins 16 secs
6.1M
150K
5.7K
2020 Mar 27
5
Easy
5
Epidemiological statistics, understanding increasing number of cases
Epidemiology-Statistics
2021 Jan 30
7
The Coronovirus explained & what you should do
Kurzgeesagt-In a Nutshell
8mins,34sec
2.8 crore
9.3 lakh
13K
2020 Mar 19
5
Very easy
5
An early overview of the virus, mechanism of transmission and sickness, and management
SARS-CoV-2, transmission and Covid-19
2021 Jan 30
8
COVID -19 Annimation: What happens if you get coronavirus?
Nucleus Medical Media
7min,27sec
2 crore
2.1 lakh
10K
2020 Mar 28
5
Very easy
5
A good general introduction to the virus and infection
SARS-CoV-2 and Covid-19
2021 Jan 30
9
Recognizing Day to Day Signs and Symptoms of coronavirus
FreeMedEducation
3min,50sec
1 crore
89K
5.8K
2020 Apr 25
5
Very easy
5
Day to Day symptoms of corona virus
Symptoms
2021 Jan 30
10
Coronavirus SARS-CoV-2 structure
Biolution
2min,16sec
390715
3.5K
143
2020 Mar 13
5
Easy
5
A good overview of structure of the virus and its contents
SARS-CoV-2
2021 Jan 30
11
Coronavirus / SARS CoV-2
Hussain Biology
5 min, 17 sec
1,91,,286
2.6K
149
2020 Feb 26
5
OK
4
Introduction to the varieties of the Coronaviruses
Corona virus types
2021 Jan 30
12
SARS-COV-2 Life cycle (Summer 2020)
RCSBProteinDataBank
4 min, 21 sec
6.4K
159
2
2020 Oct 01
5
Technical information
5
Lytic cycle of the virus, with introduction to its gene & proteins
Lytic cycle, genes and proteins
2021 Jan 30
13
Inside the lab that invented the Covid-19 vaccine
It's Okay to be smart
11 mins 50 secs
828K
36K
1.2K
2020 Dec 08
4
Easy
5
Description of production of vaccine of one type at the University of Texas. Includes good introduction of cryo-electronic microscopic determination of protein structure.
Vaccine production
2021 Jan 30
14
How the SARS-COV-2 Virus Promotes Pain Relief
University of Arizona health science
2 min, 05 sec
1119
15
0
2020 Oct 01
5
OK
5
Mechanism of pain-insensitivity induced by Sars-Cov-2
Pain insensivity
2021 Jan 30
15
SARS-CoV-2 IgG antibodies and why the receptor-biding domain of the spike protein is so important
Beckman Coulter Dx
2 min, 52 sec
7791
92
0
2020 May 26
3
OK
4
About the IGg antibodies produced from the infection and process
Antibodies
2021 Jan 30
16
COVID-19 and CD147 - An Alternative Receptor For SARS-CoV-2
Rahul's Advanced Biology
10mins,37sec
1634
83
0
2020 May 24
5
Technical information
5
Characteristics of CD 147, an alternative route for Sars-Cov-2
CD147
2021 Jan 30
17
Vitamin-D & COVID 19 : The evidence for prevention & treatment of coronavirus (SARS CoV 2)
MedCram - Medical Lectures Explained CLEARLY
1 hr 23 secs
2.9M
57K
1.6K
2020 Dec 11
4
Technical information
5
An interview on the role of vitamin D
Vitamins
2021 Jan 30
18
Covid vaccines
Doctor Klioze
14min 29secs
11200
309
1
2020 Dec 08
5
OK
5
Immunity concepts and RNA vaccines
Vaccine
2021 Jan 30
19
Covid anatomy explained:Science,simplified
Hailee perrett
2 min 01secs
42820
306
17
2020 May 14
5
OK
5
Parts of coronavirus
Anatomy
2021 Jan 30
20
Introducing SARS-CoV-2: learn the basic principles behind this virus.
Medmastery
4mins 34 secs
8145
130
9
2020 May 27
5
Technical information
5
basic microbiology of SARS-CoV-2 and describe its structural components.
basic microbiology of SARS-CoV-2
2021 Jan 22
21
How do ventilators work? - Alex Gendler
TED-Ed
5mins 31 secs
703046
21K
258
2020 May 21
3
Technical information
5
Expalins the working of ventilators , one of the main equipment used in treating ICU Covid patients
Treatment
2021 Jan 22
22
Which is better: Soap or hand sanitizer? - Alex Rosenthal and Pall Thordarson
TED-Ed
6mins 14sec
2.8million
46K
1.2K
2020 May 05
5
Easy
5
Explains how washing hands with soap will protect us from the viral infection
Treatment
2021 Jan 22
23
SARS-CoV-2 (Covid-19) Infection Process
CanalDivulgación
2mins 20sec
23707
251
16
2020 May 07
4
Technical information
4
SARS-CoV-2 (Covid-19) Infection Process
molecular biology
2021 Jan 22
24
Biology of SARS-CoV-2: Infection
Biointeractive
2mins 42 sec
13404
112
5
2020 Aug 28
5
Technical information
5
This animation describes the structure of coronaviruses like SARS-CoV-2 and how they infect humans and replicate inside cells.
Structure of SARS-CoV-2
2021 Jan 22
25
3D Animation: How Do I Protect Myself From Coronavirus, COVID-19?
Nucleus medical Media
1min 33sec
330457
4.9K
299
2020 Apr 03
5
Very easy
5
Public health advertisement
Public health
2021 Jan 22
26
How The Coronavirus Attacks Your Lungs
Deep Look
5mins 10sec
431710
15K
231
2020 May 05
5
Easy
5
How lungs are affected by coronavirus
Immunology
2021 Jan 22
27
Explainer: How the coronavirus (SARS-CoV-2) infects human cells
The Star
2mins 08secs
720536
3.9K
221
2020 Mar 16
5
Technical information
5
Animation how the virus affects the cells
molecular biology
2021 Jan 22
28
COVID-19 (SARS Coronavirus 2) - timeline, pathophysiology (ARDS), coronavirus life cycle, treatment
Armando Hasudungan
28mins 19secs
266553
3.7K
131
2020 Apr 07
5
Easy
5
Timeline of Covid-19 pandemic
Epidemiology
2021 Jan 22
29
COVID-19 | Coronavirus: Epidemiology, Pathophysiology, Diagnostics
Ninja Nerd Lectures
58mins
5.2million
88K
2.9K
2020 Mar 17
5
Technical information
5
lecture to understand the origin and zoonosis of COVID-19, the routes of transmission, epidemiology (current as of 3/15/2020), pathophysiology, and diagnostic tests used to identify COVID-19.
Epidemiology, Pathophysiology, Diagnostics
2021 Jan 22
30
COVID-19 | Coronavirus: How is Coronavirus Diagnosed |
Ninja Nerd Lectures
41mins 59secs
124481
3.5K
54
2020 Apr 21
5
Technical information
5
Detail on the diagnostics used to diagnose COVID-19.
Diagnostics
2021 Jan 22
31
The origins of SARS-CoV-2
American Society for Microbiology
2mins 51secs
2561
25
9
2020 Sep 24
5
Technical information
5
Origins of SARS-CoV-2
Moelcular biology
2021 Jan 22
32
Introduction to Coronaviruses (SARS, MERS, COVID-19): Hosts, Symptoms, History of SARS and MERS
JJ Medicine
7mins 20secs
264782
3.5K
145
2020 Feb 02
5
Easy
5
Hosts, Symptoms, History of SARS-CoV-2, SARS and MERS
molecular biology
2021 Jan 22
33
Coronavirus outbreak (covid 19) explained through 3D Medical Animation
Scientific Animations
6mins 08secs
7545329
62k
2.7K
2020 Feb 11
5
Easy
4
Coronavirus outbreak -Statistics
Pandemic outbreak
2021 Jan 22
34
Covid vaccines what do we need to know
WHO
53secs
733K
-
-
2021 Jan 22
5
Easy
5
Is it ok to mix and match COVID-19 vaccines between the first dose and the second one?
Vaccines
2021 Jan 23
35
Q&A on COVID-19 with Dr Soumya Swaminathan and Dr Maria Van Kerkhove
WHO
53mins 21 sec
512K
-
-
2020 Oct 14
5
Technical information
5
Q&A on COVID-19 with Dr Soumya Swaminathan and Dr Maria Van Kerkhove
Public health
2021 Jan 23
36
Tools to fight COVID-19
WHO
1min 10sec
347K
-
-
2020 Dec 26
4
Easy
5
Tools to fight COVID-19: Be your own superhero! We are in this together!
Public health
2021 Jan 23
37
Q&A on the new #COVID19 virus variant
WHO
40mins 36secs
822K
13K
4.5K
2020 Dec 23
5
Technical information
5
Q&A on the new COVID-19 virus variant with WHO, COVID Genomic UK, and Sanger Institute's experts
Public health
2021 Jan 23
38
Three factors help you make safer choices when you are in Covid effected area
WHO
1min
2.7K
-
-
2021 Jan 23
5
Easy
5
Animation: see how location, proximity and time can help you make safer choices when you're in an area of widespread COVID-19 transmission
Public health
2021 Jan 23
39
Coronavirus spike proteins
Thermo Scientific EM & Spectroscopy
1min 15sec
34995
255
20
2017 Nov 17
3
Easy
5
Cryo-electron microscopy (cryo-EM) is helping researchers determine the structure of coronavirus spike proteins-fueling strategies to prevent infections.
Advertisement by Thermo Scientific
2021 Jan 23
40
SARS-CoV-2 Structure (COVID-19 Coronavirus)
Molecular Memory
11mins 59 sec
186375
4.7K
96
2020 Apr 03
5
Technical information
5
A structural exploration of the proteins produced by SARS-CoV-2.
Virus structure
2021 Jan 23
41
How COVID-19 Affects the Body
Nucleus Medical Media
4mins 02sec
574562
10K
343
2020 Jun 13
5
Technical information
5
Animation showing how SARS-CoV-2 affects the body
Public health
2021 Jan 23
42
Model of Membrane Fusion by SARS CoV-2 Spike Protein
ClarafiSciViz
42secs
10471
-
-
2020 Jun 21
5
Technical information
5
A dynamic simulation and visual model of how the SARS CoV-2 Spike protein drives fusion of viral and cell membranes.
molecular biology
2021 Jan 23
43
What Happens If You Get a Severe Case of COVID-19?
Nucleus Medical Media
10mins 02sec
1052182
14K
691
2020 May 06
5
Easy
5
What can happen to a healthy person in the unlikely event they develop a severe case of COVID-19 due to coronavirus.
Public health
2021 Jan 23
44
Computer modelling generating accurate simulation of COVID-19 spike protein
CSIRO's Data61
36sec
1522
16
1
2020 Apr 16
5
Technical information
5
Accurate replica of COVID-19 to identify the regions of its proteins that could be good targets for a successful drug and minimise costly and time intensive lab testingA
molecular biology
2021 Jan 23
45
Understanding COVID-19 transmission, informing control
OxfordSparks
2mins 31 sec
8147
36
1
2020 Aug 06
3
Technical information
5
Tackling a previously unseen pathogen - like the one that causes COVID-19 - is like piecing together a puzzle. There are many different parameters to investigate before the pathogen can be fully understood, and before effective control measures can be put in place. So how do scientists go about solving the puzzle, and why is modelling so important?
Scientific and Modelling analysis
2021 Jan 23
46
Tracing the origins of SARS-CoV-2 animation
RAZOR
6mins 28secs
-
-
-
2020 Jun 07
5
Easy
5
Since the beginning of the pandemic, researchers from around the world have attempted to use it to confirm the origins of SARS-CoV-2, the novel virus that causes COVID-19. In this RAZOR animation we explore the roots of a phylogenetic tree of coronaviruses to ask - where did SARS-CoV-2 come from?
molecular biology
2021 Jan 23
47
Understanding the Virus that Causes COVID-19
Alila Medical Media
4mins 35secs
595853
4K
244
2020 Mar 28
5
Easy
5
Overview of coronavirus family, origin of SARS-CoV-2, viral structure and life cycle, pathophysiology.
Structure of SARS-CoV-2
2021 Jan 23
48
The Coronavirus Explained & What You Should Do
Kurzgesagt - In a Nutshell
8mins 34secs
28755547
944K
13K
2020 Mar 19
5
Easy
5
General explaination of
1899 Dec 30
49
COVID-19 (Pregnancy & labor management) webinar by AIIMS, New Delhi
AIIMS Telemedicine
55mins 15secs67098
794
36
2020 Apr 09
5
Medium
5
Webinar on Covid-19 : Pregrancy and labour management by SET facility , AIIMS, New Delhi
Public health
2021 Jan 29
50
Rapid Setting up of ICU AIIMS COVID-19 Webinar Series
AIIMS Telemedicine
34mins 38secs
3023
72
1
2020 Apr 08
5
Technical information
5
Webinar on Covid-19 by Prof.Anjan Trikha
Public health
2021 Jan 29
51
PPE Use in Different Areas of the Hospital
AIIMS, New Delhi
7mins 51sec
4513
127
2
2020 Apr 08
5
Technical information
5
Talk by Dr.Randeep Gularia, Director, AIIMS
Hospital management
2021 Jan 29
52
Using Personal Protection N95 Masks given to Health Care Workers at AIIMS
AIIMS, New Delhi
2mins 47secs
10207
127
3
2020 Apr 27
5
Easy
5
The recommended methods for storing and reusing the five N95 masks that have been issued for "Personal Protection" by Health Care Workers in hospital setting
Public health
2021 Jan 29
53
Re-Use of N95 Mask -JIPMER
JIPMER OFFICIAL VIDEO
10mins 25secs
16410
267
19
2020 May 30
5
Easy
5
Re-Use of N95 Mask -JIPMER
Public health
2021 Jan 29
54
COVID-19 Update 15: Can we disinfect and reuse N95 masks?
Medmastery
8mins 03secs
447504
2.9K
163
2020 Apr 07
5
Easy
5
Personal protective equipment (including masks) are vital for protecting health care workers from infection with COVID-19.
Public health
2021 Jan 29
55
Biomedical Waste management, Disinfection & Cleaning in COVID-19 Areas
AIIMS Telemedicine
11mins 27 secs
13464
187
3
2020 Apr 27
5
Technical information
5
Biomedical waste management, Appropriate disinfection, Cleaning procedures.
Public health
2021 Jan 29
56
Hydroxychloroquine & COVID-19
AIIMS, New Delhi
1min 55sec
3280
106
2
2020 Apr 27
5
Easy
5
Advice on use of Hydroxychloroquine by Dr.Randeep Gularia, Director, AIIMS
Public health
2021 Jan 29
57
COVID-19 Vaccines: MODERNA | PFIZER/BIONTECH | ASTRAZENECA
Ninja Nerd Lectures
43min 48sec
439379
15K
290
2020 Dec 07
5
Technical information
5
Lecture discussing COVID-19 vaccines including Moderna, Pfizer/BioNTech, and Astrazeneca/Oxford.
Vaccinology
2021 Jan 29
58
Coronavirus and COVID-19
Doctor Klioze
17min 04sec
42965
970
20
2020 Apr 19
5
Easy
5
Describes the physiology and potential treatment options of the SARS-CoV2 viral infection.
Molecular biology
2021 Jan 29
59
General Public: Care for Yourself
Centers for Disease Control and Prevention (CDC)
25secs
4326
63
15
2021 Jan 02
5
Easy
5
Tips to encourage taking care of yourself one small way each day. The COVID-19 pandemic may be stressful for people. Coping with stress in a healthy way will make you, the people you care about, and your community stronger.
Public health
2021 Jan 29
60
How to Clean and Disinfect Your Home if Someone has COVID-19
Centers for Disease Control and Prevention (CDC)
2mins 03secs
244939
1.5K
102
2020 Aug 24
5
Easy
5
Follow these tips for cleaning and disinfecting your home
Public health
2021 Jan 29
61
CDC COVID-19 Prevention Messages for Front Line Long-Term Care Staff: PPE Lessons
Centers for Disease Control and Prevention (CDC)
12mins 01sec
348046
796
88
2020 Apr 27
5
Easy
5
Learn what personal protective equipment (PPE) should be used in Long-Term Care facilities and Nursing Homes, when, and how to use it correctly to help protect yourself and residents from COVID-19.
Public health
2021 Jan 29
62
COVID-19: Questions and Answers
Centers for Disease Control and Prevention (CDC)
10mins 53secs
19781
169
32
2020 Nov 20
5
Technical information
5
CDC's Dr. Henry Walke answers common questions about COVID-19.
Public health
2021 Jan 29
63
Healthy Workplaces - Tips and Tools for Operating your Business
Centers for Disease Control and Prevention (CDC)
1hr 20secs
1111
7
1
2020 Nov 21
5
Technical information
5
Dr. McDonald shared updates on CDC's COVID-19 response, including the latest scientific information and what everyone should know about protecting themselves and others
Public health
2021 Jan 29
64
What to Expect After Getting a COVID-19 Vaccine
Centers for Disease Control and Prevention (CDC)
1min 27secs
67616
323
388
2020 Dec 18
5
Easy
5
After getting a #COVID19 vaccine, you may have some side effects, which are normal signs that your body is building protection against COVID-19. Call your healthcare provider if redness or tenderness increases after 24 hours, if your side effects are worrying you, or if they do not seem to be going away after a few days.
Public health
2021 Jan 29
65
What Clinicians Need to Know About Pfizer-BioNTech and Moderna Vaccines
Centers for Disease Control and Prevention (CDC)
59mins 22secs
7578
98
16
2020 Dec 21
5
Technical information
5
This video (COCA Call) will give clinicians an overview of the Pfizer-BioNTech and Moderna COVID-19 vaccines. Clinicians will learn about vaccine characteristics and administration, vaccinating special populations, and contraindications. They will also get answers to a number of clinical questions CDC has received about these new vaccines.
Medicine
2021 Jan 29
66
Religious Leaders and Prevention
Centers for Disease Control and Prevention (CDC)
2mins 41secs
353
1
1
2020 Dec 31
5
Easy
5
Global faith leaders can encourage everyone in the community to practice prevention strategies that help reduce the spread of COVID-19
Public health
2021 Jan 29
67
What Your Test Results Mean
Centers for Disease Control and Prevention (CDC)
44secs
4383
32
14
2020 Oct 28
5
Easy
5
Actions to take to protect yourself and others when you receive either a negative or a positive COVID-19 test result.
Public health
2021 Jan 29
68
Do it for Yourself and Your Friends
Centers for Disease Control and Prevention (CDC)
31secs
3179
44
13
2020 Oct 29
5
Easy
5
Tips for preventing the spread of COVID-19 to you and your friends.
Public health
2021 Jan 29
69
Help Protect Yourself and Others
Centers for Disease Control and Prevention (CDC)
47secs
7503
75
46
2020 Oct 30
5
Easy
5
Help Protect Yourself and Others from COVID-19
Public health
2021 Jan 29
70
Lecture 1: "COVID-19 and the pandemic"
MIT Department of Biology
56min 10secs
45631
-
-
2020 Sep 04
5
Technical information
5
The first lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Dr. Bruce Walker,eminent immunologist. founding directior of the Ragon Institute of MGH, MIT and Harvard gave a talk titled "Evolution of Covid-19 Pandemic: learning from the patients."
Immunology, Epidemiology
2021 Jan 29
71
Lecture 2: "Coronavirus biology"
MIT Department of Biology
56mins 08sec
28620
-
-
2020 Sep 10
5
Technical information
5
The second lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Britt Glaunsinger of the University of California, Berkeley gave a talk titled "Coronavirus biology."
Molecular biology
2021 Jan 29
72
Lecture 3: "Virology and lessons from the AIDS pandemic"
MIT Department of Biology
56mins 45sec
12239
-
-
2020 Sep 16
5
Technical information
5
The third lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. David Baltimore of Caltech gave a talk titled "Virology and lessons from the AIDS pandemic."
Epidemiology
2021 Jan 29
73
Lecture 4: "Insights from the COVID-19 pandemic"
MIT Department of Biology
48mis 47secs
94940
-
-
2020 Sep 25
5
Technical information
5
The fourth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), gave a talk titled "Insights from the COVID-19 pandemic."
Public health
2021 Jan 29
74
Lecture 5: "Viral immunology"
MIT Department of Biology
56mins 38secs
14376
-
-
2020 Oct 03
5
Technical information
5
The fifth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Michel Nussenzweig of The Rockefeller University gave a talk titled "Viral immunology."
Immunology
2021 Jan 29
75
Lecture 6: "Target cells and the innate response"
MIT Department of Biology
54mins 21secs
11608
-
-
2020 Oct 13
5
Technical information
5
The sixth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Shiv Pillai of the Ragon Institute and MGH gave a talk titled "Target cells and the innate response."
Immunology
2021 Jan 29
76
Lecture 7: "The patient"
MIT Department of Biology
57mins 06sec
7458
-
-
2020 Oct 22
5
Technical information
5
The seventh lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Victoria Clark of Whitehead Institute and MGH gave a talk titled "The patient."
2021 Jan 29
77
Lecture 8: "Epidemiology"
MIT Department of Biology
55mis 49sec
10092
-
-
2020 Oct 30
5
Technical information
5
The eighth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Michael Mina of the Harvard T. H. Chan School of Public Health gave a talk titled "Epidemiology."
Epidemiology
2021 Jan 29
78
Lecture 9: "Immunology: T cells"
MIT Department of Biology
57mins 01secs
8098
-
-
2020 Nov 06
5
Technical information
5
The ninth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Arlene Sharpe of Harvard Medical School gave a talk titled "Immunology: T cells."
Immunology
2021 Jan 29
79
Lecture 10: "Vaccines"
MIT Department of Biology
56mins
18116
-
-
2020 Nov 15
5
Technical information
5
The tenth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Kizzmekia Corbett of the National Institutes of Health gave a talk titled "Vaccines."
Vaccinology, Immunology
2021 Jan 29
80
Lecture 11: "Immunology: antibodies"
MIT Department of Biology
53 mins
26645
-
-
2020 Nov 19
5
Technical information
5
The eleventh lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Akiko Iwasaki of Yale Medical School gave a talk titled "Immunology: antibodies."
Immunology
2021 Jan 29
81
Lecture 12: "Small molecule therapeutics"
MIT Department of Biology
56mins 54secs
5453
-
-
2020 Nov 27
5
Technical information
5
The twelfth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. James Bradner of Novartis Institutes gave a talk titled "Small molecule therapeutics."
Vaccinology, Immunology
2021 Jan 29
82
Lecture 13: "Therapeutics discovery"
MIT Department of Biology
1hr 02min 06sec
4555
-
-
2020 Dec 03
5
Technical information
5
The thirteenth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Skip Virgin of Vir Biotechnology gave a talk titled "Therapeutics discovery."
Vaccinology, Immunology, Therapeutics
2021 Jan 29
83
Lecture 14: "Rapid research response in a pandemic"
MIT Department of Biology
56mins 21 secs
3628
-
-
2020 Dec 10
5
Technical information
5
The fourteenth lecture in the COVID-19, SARS-CoV-2 and the Pandemic Series, presented by the MIT Department of Biology. Dr. Eric Lander of Broad Institute gave a talk titled "Rapid research response in a pandemic."
Diagnostics
2021 Jan 29
84
Distinguished Speaker: Covid-19 Vaccine, from discovery to delivery
JHUCareyBusiness
1hr 27mins
35
-
-
2021 Jan 27
5
Technical information
5
The development and deployment of an effective vaccine for COVID-19 could be the turning point in the fight against the deadly pandemic. A distinguished panel of public health experts and vaccine industry executives for an engaging discussion examining every aspect of the COVID-19 vaccine from discovery to manufacturing to delivery.
Business, Economics, Vaccines
2021 Jan 29
85
Coronaviruses 101: Focus on Molecular Virology
Innovative Genomics Institute - IGI
1hr 02 secs
361516
7.6K
171
2020 Mar 25
5
Technical information
5
UC Berkeley professor and IGI Investigator Britt Glaunsinger, PhD, explains the evolution, genetics, and virulence of coronaviruses.
Microbiology
2021 Jan 29
86
COVID Catalysts | The biotechnology revolution delivering a greener and cleaner future
The University of Manchester
6mins 25sec
194
5
-
2020 Oct 16
5
Technical information
5
Robert Field, Professor of Chemistry talks how Biotechnology promises a revolution in the way we make our future medicines, materials and fuels.
Careers
2021 Jan 29
87
Dr. Kizzmekia Corbett: Everything You Should Know About the COVID-19 Vaccines
Urban Health Institute and Johns Hopkins Office of Diversity, Inclusion, and Health Equity
1hr 32mins
-
-
-
2021 Jan 27
5
Technical information
5
Webinar on Covid-19 vaccines by Dr. Kizzmekia Corbett- Scientific team: Coronavirus Vaccine team , NIH, NIAID, Vaccine reasearch centre
Vaccinology, Community medicine
2021 Jan 29
88
Coronavirus Update With Peter Piot, MD, PhD - Director of The London School of Hygiene and Tropical Medicine
JAMA Network
47mins 53secs
4122
1981
5
2021 Jan 28
5
Technical information
5
JAMA's Q&A series to discuss the global public health response to COVID-19 past, present, and future.
Epidemiology, Expert talk
2021 Jan 29
89
Preserving the Scientific Integrity of Getting to COVID-19 Vaccines : From Clinical Trials to Public Allocation
Johns Hopkins University
2hrs 55mis
8301
-
-
2020 Oct 07
5
Technical information
5
Johns Hopkins University and the University of Washington are bringing together leading experts to explore these issues and put forward a concise plan for protecting the scientific integrity of these lifesaving efforts.
Expert talk
2021 Jan 29
90
Part 2: Protecting Scientific Integrity in the Design & Conduct of COVID-19 Vaccine Efficacy Trials
Johns Hopkins University
40mins 44 secs
549
-
-
2020 Oct 09
5
Technical information
5
Protecting Scientific Integrity in the Design & Conduct of COVID-19 Vaccine Efficacy Trials : Design, execution and analysis of ongoing and planned COVID-19 vaccine trails
Expert talk
2021 Jan 29
91
ASL: I wear a mask because
Centers for Disease Control and Prevention (CDC)
30secs
542
4
6
2020 Oct 30
5
Easy
5
Why do we wear a mask? - with ASL
Public health advetisement
2021 Jan 29
92
3D Annimation: SARS-CoV-2 virus transmission leading to COVID -19
Nucleus Medical Media
1min,31 sec
18 lakh
15K
964
2020 Apr 01
5
Easy
5
Virus transmission
Transmission
2021 Jan 30
93
Structure of Coronavirus with classification of viruses
Physiology Open
5 mins 51 secs
18K
427
12
2020 Mar 28
5
Easy
5
General virus, contents, types and the corona virus
Corona virus types
2021 Jan 30
94
Coronavirus Update 59: Dr. Roger Seheult's Daily Regimen (Vitamin D, C, Zinc, Quercetin, NAC
MedCram
18 mins 32 secs
584K
14K
296
2020 Apr 22
5
Easy
5
Information, with research evidence, on signficance of vitamins and other nutrition-supplements, tips for health professionals who fight Covid-19;
Vitamins & Covid-19
2021 Jan 30
95
How Coronavirus Kills: Acute Respiratory Distress Syndrome (ARDS) & COVID 19 Treatment
MedCram
11 mins 04 sec
4016K
56K
1.8K
2020 Jan 29
5
Easy
5
Brief & clear explanation of what happens to patients in severe cases, and description of modification of ventilation procedures, with references that provided evidences
Patient care
2021 Jan 30
96
Astrazeneca : Biomanufacturing a COVID-19 vector vaccine
Astrazeneca
2mins 12 secs
-
-
-
2020 Oct 01
5
Easy
5
Animation of biomanufacturing a COVID-19 vector vaccine
Bioengineering, Vaccines
2021 Jan 29
97
COVID-19 vaccine from any country will work in India: CCMB
TNIE Videos
1mins 40secs
1084
8
1
2020 Sep 20
5
Easy
5
News bit from the New Indian Express and CCMB
News Video
2021 Jan 29
98
New variant causes more symptoms
Dr. John Campbell
30mins 52 secs
240323
8.6K
308
2021 Jan 28
5
Technical information
5
Coronavirus (COVID-19) Infection Survey: characteristics of people testing positive for COVID-19 in England
Symptoms
2021 Feb 01
99
Covid-19: Vaccine Roll-out, the State of the Pandemic, and Variants -- in the U.S. and U.K.
UCSF School of Medicine
1hr 19mins
7157
-
-
2021 Jan 29
5
Technical information
5
In this UCSF Department of Medicine Covid Grand Rounds, Susan Philip, the acting Health Officer for the SF Department of Public Health, will give us an update on vaccine distribution in San Francisco. Exploring the new viral variants from two perspectives. Shane Crotty, Professor of Immunology at the La Jolla Institute, will describe our evolving understanding of all of the variants, what they mean for California and the U.S., and how we should respond. Sir Patrick Vallance, Chief Scientific Adviser for the United Kingdom, will discuss the UK's experience with the B117 variant, including emerging information that the variant may not only be more infectious but potentially more likely to be fatal too.
Immunology, Epidemiology
2021 Feb 01
100
What you need to know about spring allergies and COVID-19
Mayo Clinic
3mins 24secs
21780
96
13
2020 Apr 03
5
Easy
5
with the arrival of spring comes an increase in seasonal allergies and now questions about increased risk related to COVID-19. "Currently, there is no data to substantiate those patients with allergies and asthma are at an increased risk for COVID-19. And there's nothing in the literature to suggest that COVID-19 affects these people differently," says Dr. Arveen Bhasin, a Mayo Clinic allergy and immunology specialist.
Symptoms
2021 Feb 01
101
Home Care Tips For Mild COVID-19 Cases by Dr. Sushila Kataria
Medanta
7mins 17secs
1631107
34K
780
2020 Jul 20
5
Easy
5
Dr. Sushila Kataria, Senior Director, Internal Medicine, Medanta Gurugram shares home care tips for patients with mild COVID-19 symptoms, who have been advised home isolation by their doctors.
Public health
2021 Feb 01
102
How does COVID-19 affect the heart?
Mayo Clinic
4mins 48secs
48441
482
22
2020 Apr 03
5
Easy
5
The effects of COVID-19 on the lungs are well-known. As the COVID-19 pandemic continues, more information is becoming available about the role the virus, called SARS-CoV-2, has on the heart. "Individuals with known cardiovascular disease are at an increased risk of more severe complications from respiratory viral illnesses, including the flu and COVID-19," says Dr. Leslie Cooper, chair of the Department of Cardiology at Mayo Clinic.
Symptoms
2021 Feb 01
103
The Effects of COVID-19 on the Heart: Patient Andre Taylor's story
MedStar Washington Hospital Center
3mins 41secs
684
8
0
2020 Oct 15
5
Easy
5
Patient André Taylor beat coronavirus, but he developed abnormal heart rhythms, likely from his bout with COVID-19. Dr. Cyrus Hadadi of MedStar Washington Hospital Center tell Washington why some COVID-19 patients show signs of heart damage, even weeks or months after feeling better.
Medicine
2021 Feb 01
104
Heart Muscle Damage from COVID-19
GIBLIB
8mins 56secs
17250
139
9
2020 Sep 01
5
Easy
5
From the beginning of the COVID-19 pandemic, it was that known the disease affected the lungs. But some of the most severe damage to the body can be to the heart muscle. COVID-related myocarditis, or inflammation of the heart muscle, can cause severe damage and sometimes death. Mayo Clinic Q&A podcast, Dr. Leslie Cooper, chair of Cardiology at Mayo Clinic in Florida, discusses how COVID-19 affects the heart in hospitalized patients, in young people and he identifies areas of research that need to be pursued in the near future.
Medicine
2021 Feb 01
105
How to diagnose POST COVID 19 chest pain crowing rooster maneuver
Dr KK Aggarwal
2mins 44secs
54148
1.1K
26
2020 Aug 10
4
Easy
5
Difference between heart pain and Costo chondritis
Medicine
2021 Feb 01
106
Covid 19 - Home Exercises Program to improve Lung capacity
Dr.Smita Ingle
29mins 38secs
738277
10K
414
2020 Mar 31
5
Easy
5
Exercises to Improve your Lung capacity
Public health
2021 Feb 01
107
How coronavirus antibody tests work and why they matter | COVID-19 Special
DW News
12mins 45secs
83275
887
55
2020 Apr 14
3
Easy
5
Antibodies are also used in vaccines to make people immune to future infections. But immunity doesn't last a lifetime in all cases. So what do we know about Sars-CoV-2? How long will people be immune after an infection?
Epidemiology, News video
2021 Feb 01
108
Oxford University's 'vaccine for the world' is effective
University of Oxford
47secs
16944
369
12
2020 Nov 23
5
Easy
5
The interim phase III trial results are in: Oxford University's COVID-19 vaccine is effective.
Vaccine
2021 Feb 01
109
Covishield Vaccine: All You Need to Know
NDTV
1mins 51secs
7426
77
9
2021 Jan 02
5
Easy
5
The Oxford-AstraZenenca covid-19 vaccine - being developed by Serum Institute - will be called 'COVISHIELD'. Partial results from studies that saw participation of about 24,000 people in Britain, Brazil and South Africa suggest the AstraZeneca shots are safe and about 70 per cent effective in preventing coronavirus infection. The vaccine is expected to be used in many countries because of its low cost and the fact that it can be kept in refrigerators instead of the ultra-cold or freezer temperatures. The vaccine can be stored at 2-8 Degrees for at least six months.
Vaccine, News video
2021 Feb 01
110
Frequently asked Queries about Indian Covid Vaccines COVISHIELD and COVAXIN (HINDI)
Dr. Sparsh Gupta - Pathology
7mins 51 secs
42276
3K
36
2021 Jan 24
5
Easy
5
This is an educational video based on the Guidelines issued by the Government of India.
Vaccine
2021 Feb 01
111
India's COVAXIN vs American COVID Vaccines | Cheaper , Better ? (Hindi)
Gareeb Scientist
14mins 05secs
347749
12K
395
2020 Dec 08
5
Easy
4
India's Bharat Biotech is developing COVAXIN, how is different from foreign american vaccines? we will compare the differences.
Vaccine
2021 Feb 01
112
Testing face masks: Lab tests reveal the safest and most effective (Marketplace)
CBC News
7mins 41secs
891240
11K
844
2020 Nov 14
5
Easy
5
How effective are your face masks? Months into the coronavirus pandemic there are still no standards or regulations for consumer masks. So we asked the University of Toronto to test more than 20 different masks. We reveal which are the most effective at keeping you safe from COVID-19, and which masks you should avoid.
Public health
2021 Feb 01
113
What to expect if you're diagnosed with COVID-19
UCLA Health
8mins 24secs
10741
216
12
2020 Dec 16
5
Easy
5
If you are diagnosed with COVID-19, please keep in mind that most people do very well and are able to take care of themselves at home, without ever being hospitalized. This video includes information on how to isolate and care for yourself at home, and what to do if you experience troubling symptoms.
Public health
2021 Feb 02
114
COVID-19: The Science of How we Got Here and Where we are Headed
University of California Television (UCTV)
1hr 28mins
3155
118
10
2020 Nov 23
5
Technical information
5
Dr. George Rutherford, a professor of epidemiology and biostatistics at UCSF, explores what we know about SARS-CoV-2, the virus that causes COVID-19, and what the future holds. He talks about intervention, vaccines and models of super spreading.
Epidemiology
2021 Feb 02
115
Aerosolized Nanobodies for SARS-COV-2 Passive Immunization
University of California Television (UCTV)
1hr 25mins
3012
110
7
2020 Oct 31
5
Technical information
5
As the world awaits vaccines to bring the COVID-19 pandemic under control, UC San Francisco scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease. They are focused on the potential of virus-neutralizing monoclonal antibodies (mAbs) to treat COVID-19 by passive immunization.
Therapeutics
2021 Feb 02
116
Is COVID-19 a Heart Disease?
University of California Television (UCTV)
1hr 17mins
6850
182
7
2020 Nov 21
5
Technical information
5
COVID-19 was initially identified as a respiratory disease, but scientists now know that it also affects several other organs in the body, including the heart. Heart damage is a major determinant of COVID-19 related deaths, and even patients who experience only mild COVID-19 symptoms exhibit signs of cardiac dysfunction after recovery. UCSF researchers Todd McDevitt and Bruce Conklin explore how SARS-CoV-2, the virus that causes COVID-19, inflicts damage on heart cells.
Medicine
2021 Feb 02
117
Diagnosing and Tracking COVID-19
University of California Television (UCTV)
57mins 11secs
3352
80
9
2020 Jun 13
5
Technical information
5
Dr. Chaz Langelier, UCSF Infectious Disease experts, talks about the importance of widespread testing for a disease that spreads through asymptotic or pre-symptomatic individuals. He also talks about lower respiratory tract infections (LRTI), the leading cause of death due to infection. C
Diagnostics
2021 Feb 02
118
Targeting COVID-19 Viral Enzymes
University of California Television (UCTV)
1hr 06mins
1633
61
5
2020 Dec 06
5
Technical information
5
UCSF scientists studying a key enzyme used by the virus that causes COVID-19 have identified chemical building blocks that might eventually be used to make an antiviral drug. The chemical fragments could bind to and disable the enzyme, called the "macro domain," which is a crucial part of the SARS-CoV-2 virus's ability to replicate in human cells. James Fraser discusses the finding from this research.
Structure, Molecular interactions
2021 Feb 02
119
COVID-19 Testing, Surveillance, and Diagnosis: Notes from a Disease Detective
University of California Television (UCTV)
1hr 19mins
2179
62
8
2020 Nov 07
5
Technical information
5
Dr. Charles Chiu, UCSF Professor, Department of Laboratory Medicine and Medicine / Infectious Diseases, explores the various tests and their features. He also talks about SARS-CoV-2 genomic sequencing and its uses and a new study to identify biomarkers of the virus.
Diagnostics
2021 Feb 02
120
How vaccines work against COVID-19: Science, Simplified
Scripps research
2min16sec
92k
792
63
2020 Dec 18
5
Easy
5
mRNA vaccines
Vaccine
2021 Feb 02
121
COVID-19 and Breastfeeding
University of California Television (UCTV)
1min 18sec
2500
24
11
2020 Oct 28
5
Easy
5
Can I breastfeed if I have COVID-19? Dr. Julia Cormano explains what you need to know to safely breastfeed if you are ill.
Public health
2021 Feb 02
122
Identifying the Peptides that Activate T Cells in COVID-19 Patients - Albert Wong
University of California Television (UCTV)
12mins 55secs
1256
56
3
2020 Sep 25
5
Easy
5
Identifying the Peptides that Activate T Cells in COVID-19 Patients
Immunology
2021 Feb 02
123
Coping with COVID-19: Mental Health Strategies - Health Talks
University of California Television (UCTV)
1hr
1794
43
1
2020 Jun 27
5
Technical information
5
Experts from the UC San Diego Department of Psychiatry talk about the impacts of COVID-19 on memtal health. They share tips for managing anxiety in children, the health consequences of negative experiences, suicide prevention, effective mental health treatments, treatment during the pandemic and much more.
Public health
2021 Feb 02
124
The COVID-19 Pandemic: Insights and Overview
The Rockefeller University
1hr 18mins
395
11
1
2021 Jan 15
5
Technical information
5
Neutralizing Antibodies: Precision-guided Weapons against SARS-CoV-2. Marina Caskey, M.D., professor of clinical investigation, Laboratory of Molecular Immunology at The Rockefeller University
Immunology, Therapeutics
2021 Feb 02
125
COVID-19 Testing and Biosafety Practices
ICMR Organisation
20mins 37secs
3036
91
1
2020 Jun 16
3
Easy
5
COVID-19 Testing and Biosafety Practices developed by ICMR- National Institute of Virology, Pune
Testing and biosafety
2021 Feb 02
126
Are COVID-19 vaccines safe for people with autoimmune diseases?
WHO
42secs
125K
-
-
2021 Jan 31
3
Easy
5
Are COVID-19 vaccines safe for people with autoimmune diseases?
Public health
2021 Feb 02
127
We can outsmart the COVID-19 virus
WHO
55secs
2.1million
-
-
2021 Jan 29
3
Easy
5
Be your own superhero: -clean your hands, open windows, wear a mask, keep physical distance, cough/sneeze in your elbow -Dr. Maria Van Kerhnove
Public health
2021 Feb 02
128
COVID-19 Vaccines: What Is An mRNA Vaccine?
Vanderbilt Health
1min 16secs
2768
-
-
2020 Dec 15
4
Easy
5
Covid-19 and vaccines
Vaccines
2021 Feb 02
129
COVID-19 Vaccine 101: Will a Vaccine Be Safe?
Vanderbilt Health
4mins 21secs
1452
_
-
2020 Dec 15
5
Easy
5
Covid-19 and vaccines
Vaccines
2021 Feb 02
130
"Post-acute COVID-19 Syndrome": COVID "long-haulers" suffering symptoms months after initial diagnosis
60minutes
13mins
1236959
19K
1.1K
2020 Nov 24
5
Easy
5
Anderson Cooper reports how doctors are still searching for answers to why a portion of people who were diagnosed with COVID-19 are still suffering symptoms months later.
Symptoms
2021 Feb 07
131
Long Covid: When coronavirus symptoms don't go away
DW News
12mins 33secs
252496
2.9K
133
2020 Dec 13
5
Easy
5
Many cases where patients develop mild symptoms that only last for a few weeks or show no symptoms at all. And then, there's long Covid. That's when patients still experience symptoms months after a Covid infection. There's still a lot that researchers don't understand about the novel coronavirus - and the same goes for long Covid.
Symptoms
2021 Feb 07
132
A Visual Guide to the New Coronavirus Variants
Scientific American
6mins 22secs
5524
121
4
2021 Feb 11
5
Medium
5
The more viruses that exist in the world, the greater the chance that one will evolve a dangerous mutation.In this video, we explain what the new variants actually are, how they arise and spread, and what they could mean for the future of our ability to vaccinate ourselves against the virus.
Mutations
2021 Feb 18
133
COVID-19: The New Variants |
Al Jazeera English
6mins 40secs
80957
1.8K
130
2021 Jan 18
5
Easy
5
The virus that causes COVID-19 is mutating and spreading around the world. It's led to more contagious variants, including one that's caused an unprecedented spike in cases in the UK. Vaccine roll-outs are in full swing but will they still work?
Mutations
2021 Feb 18
134
The New Vaccines, Attitudes Toward Vaccination, and the Biden Covid-19 Task Force
UCSF School of Medicine
1hr 36mins
13912
~
~
2021 Feb 12
5
Technical information
5
n this UCSF Department of Medicine Covid Grand Rounds, we'll begin with a discussion of the new vaccine candidates. Just in the past few weeks, we've seen new data regarding several vaccines, including J&J, AstraZeneca, and Novavax.
Vaccines
2021 Feb 18
135
Understanding what's driving coronavirus mutations | COVID-19 Special
DW News
11mins 52sec
175165
1.7K
118
2021 Jan 29
5
Technical information
5
New mutations have seen the virus spread like wildfire in parts of the world. Over a year after the virus was first reported, there are now a large number of strains. Some, like the variants detected in the UK and South Africa, seem to be spreading much faster. Each new infection opens the door to unknown variants which threaten to undo the progress that has been made in the fight against the pandemic. The big question is: will the existing vaccines still work?
Vaccines, Mutations
2021 Feb 18
136
How dangerous is South Africa's coronavirus variant? | COVID-19 Special
DW News
15mins 18secs
145318
1.3K
121
2021 Feb 08
5
Technical information
5
South African scientists are downplaying the danger of a new Covid-19 variant identified in the country towards the end of 2020. Covid-19 501.V2 has been found in all of the country's nine provinces and has led to several countries banning flights from South Africa. The variant has been associated with a higher viral load, leading some scientists to believe it is more transmissible and possibly a major contributing factor in the surge in infections around the globe. However the government & leading scientists are blaming the current surge in infections to a lack of adherence to coronavirus containment measures and "superspreader" events during the festive period.
Vaccines, Mutations
2021 Feb 18
137
Life Cycle of the Coronavirus
Johns Hopkins Bloomberg School of Public Health
2mins 42 secs
65601
217
18
2020 Jul 13
5
Easy
5
How does SARS-CoV2 infect people, and what are researchers learning about its possible vulnerabilities?
Molecular biology
2021 Feb 20
138
Coronavirus Update With CDC Director Rochelle Walensky
JAMA Network
38mins 21secs
13772
331
24
2021 Feb 18
5
Technical information
5
Centers for Disease Control and Prevention (CDC) Director Rochelle P. Walensky, MD, MPH discusses the agency's response to emerging variants, implications for the planned vaccine mobilization strategy, the upcoming J&J vaccine FDA advisory hearings, strategies for reopening K-12 schools, and other agency activities and priorities related to COVID-19 control.
Variants, Public health
2021 Feb 20
139
Coronavirus mRNA Vaccine Safety and Efficacy
JAMA Network
9mins 36secs
4035
2021 Feb 19
5
Easy
5
Millions of people are now being immunized with mRNA vaccines from Pfizer-BioNTech and Moderna. Both vaccines have very high efficacy and look safe in the short-term. This video reviews experience with the vaccines since they were authorized for use in December 2020
Vaccines
2021 Feb 20
140
Coronavirus Update With Anthony Fauci
JAMA Network
24mins
38475
790
61
2021 Feb 04
5
Technical information
5
Emerging genetic variants and implications for vaccine efficacy and prospects for new vaccine
Vaccines, Variants
2021 Feb 20
141
Coronavirus Variants - What They Mean
JAMA Network
36mins 08secs
25764
580
20
2021 Feb 05
5
Technical information
5
explain the variants and what they mean for public health.
Vaccines, Variants
2021 Feb 20
142
Coronavirus Vaccine Update With Paul Offit
JAMA Network
34mins 39secs
29032
574
40
2021 Feb 12
5
Technical information
5
Paul A. Offit, MD of the Children's Hospital of Philadelphia provides an update on the emergence of COVID-19 variants and their implications for vaccine development, including the JNJ vaccine, scheduled for a .S. Food and Drug Administration VRBPAC hearing on February 26, 2021.
Vaccines, Variants
2021 Feb 20
143
Coronavirus Vaccines - An Introduction
JAMA Network
9mins 53secs
9740330
43K
17K
2020 Oct 02
5
Easy
5
Leading COVID-19 vaccine candidates rely on new technologies that have fast-tracked development and testing. Vaccines from Pfizer and Moderna have completed early phase 3 clinical trials and are reportedly under review at the US FDA for emergency use authorization (EUA) although safety surveillance continues. This video explains the principles underlying the leading DNA, messenger RNA (mRNA), and viral vector vaccine candidates, and how they might induce immunity to SARS-CoV-2 infection.
Vaccines
2021 Feb 20
144
Coronavirus Treatment and Prevention With Monoclonal Antibodies
JAMA Network
5mins 55 secs
301283
12K
213
2020 Jul 01
5
Easy
5
Neutralizing monoclonal antibodies (mAbs) may be a highly effective way to treat and prevent COVID-19 while waiting for a vaccine. Watch this video to find out how these drugs are created and how they target the SARS-CoV-2 virus.
Medicine
2021 Feb 20
145
COVID Vaccination in Pregnant and Breastfeeding Individuals
JAMA Network
41mins 58secs
38571
2021 Feb 09
5
Technical information
5
As U.S. vaccine distribution expands to include younger healthier populations, questions about vaccine safety in women of childbearing age have become more urgent. UTSWMed 's Catherine Y. Spong, MD and Emory Healthcare 's Denise J. Jamieson, MD, MPH, both eminent obstetrician/gynecologists, discuss the safety of the Pfizer/BioNTech and Moderna vaccination in pregnant and nursing moms, and in women trying to get pregnant.
Vaccines
2021 Feb 20
146
Zinc and Vitamin C for COVID-19 Symptoms
JAMA Network
24mins 19secs
3828
123
13
2021 Feb 17
4
Technical information
5
Milind Y. Desai, MD, MBA, discusses a randomized clinical trial examining whether high-dose zinc and/or high-dose ascorbic acid reduces the severity or duration of symptoms compared with usual care among ambulatory patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Symptoms
2021 Feb 20
147
The Science Behind Why New Covid Variants Are Spreading Faster
Wall Street Journal
7mins 01secs
40716
727
226
2021 Feb 19
5
Technical information
5
As highly transmissible coronavirus variants sweep across the world, scientists are racing to understand why these new versions of the virus are spreading faster, and what this could mean for vaccine efforts. New research says the key may be the spike protein, which gives the coronavirus its unmistakable shape.
Variants, Public health
2021 Feb 20
148
Herd Immunity as a Coronavirus Pandemic Strategy
JAMA Network
56mins 57secs
44590
811
44
2020 Nov 07
5
Technical information
5
Would letting coronavirus infect the broad US and global population be a safe and effective means of ending the COVID-19 pandemic? Jay Bhattacharya, MD, PhD, of Stanford University's Center for Primary Care and Outcomes Research is a signatory of the 'Great Barrington Declaration,' which proposes to "allow those at minimal risk of death to live their lives normally to build up immunity to the virus through natural infection, while better protecting those who are at highest risk." Marc Lipsitch, PhD, of the Harvard T.H. Chan School of Public Health, a signatory of the 'John Snow Memorandum' which refutes the argument, responds.
Public health, Immunology, Ethics
2021 Feb 20
149
SARS-CoV-2 Life Cycle
RCSBProteinDataBank
4mins 21secs
11646
201
7
2020 Oct 01
5
Technical information
5
Overview of SARS-CoV-2 life cycle
Molecular biology
2021 Feb 20
150
SARS-CoV-2 Evolution
RCSBProteinDataBank
1min 40secs
1698
46
1
2020 Oct 01
5
Technical information
5
This video discusses where the SARS-CoV-2 infection may have come from and how it has been evolving as it spreads around the world (between late 2019 and middle of 2020)
Evolution
2021 Feb 20
151
SARS-CoV-2 Main Protease
RCSBProteinDataBank
55secs
1261
33
1
2020 Oct 01
5
Technical information
5
This video showcases the overall structure of the SARS-CoV-2 Main Protease enzyme and discusses its and functi
Structure, Molecular interactions
2021 Feb 20
152
Developing SARS-CoV-2 Vaccines (2020)
RCSBProteinDataBank
14mins 53secs
1668
38
0
2020 Oct 01
5
Medium
5
This video describes the approaches that are being used to develop a SARS-CoV-2 vaccine, using knowledge accumulated from studying other coronaviruses. Short lecture by Dr. Lisa Denzin, Rutgers University.
Vaccines
2021 Feb 20
153
SARS-CoV-2 Variants | UK + South African + Brazil Variants
Ninja Nerd Lectures
42mins 59secs
16738
1.7K
3
2020 Feb 15
5
Technical information
5
This video discusses discuss the three primary variants we are currently aware of. The first variant we discuss is the UK variant, also known as B.1.1.7. Next we discuss the South African variant, also known as B.1.351. Finally, we break down the science behind the Brazil variant, also known as P.1.
Viral variants
2021 Feb 20
154
The Spike story
RCSBProteinDataBank
1min 45secs
1948
76
1
2020 Oct 01
5
Technical information
5
This video illustrates the structures of the SARS-CoV-2 Spike protein and human ACE2 binding - a step that begins the infection.
Structure
2021 Feb 20
155
How coronaviruses get into cells
Tom Goddard
17mins 53secs
34494
1.1K
26
2020 Feb 04
5
Technical information
5
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
2021 Feb 20
156
Headache and COVID-19
IHS International Headache Society
7mins 40secs
28
4
2020 Nov 09
5
Technical information
5
Covid -19 and headache related information
Public health
2021 Feb 21
157
New cornonavirus variants-Explained simply
Genomics Gurus
56mins 39secs
6068
130
8
2021 Jan 08
5
Easy
5
This video explains coronavirus variants, mutations, PCR tests in simple terms, so that you can make more sense of media reports and the changing restrictions to our daily lives. You will also learn some cool molecular biology!
Molecular biology
2021 Feb 24
158
Quick look at 3 new coonavirus variants
Genomics Gurus
8mins 04secs
4967
116
4
2021 Jan 22
5
Easy
5
A quick look at the three new coronavirus variants from the UK, South Africa and Brazil. This video summarises the SARS-CoV-2 mutations and what the main clinical features of these variants are.
Variants
2021 Feb 24
159
The spread of 3 new coronavirus variants - A close look at the scientific data
Genomics Gurus
1hr 05mins
817
24
1
2021 Jan 20
5
Techincal information
5
This presentation gathers together all the scientific data about the rapid spread of three new coronavirus variants that are changing how we need to manage the COVID-19 pandemic.
Variants
2021 Feb 24
160
Delivery strategies and infection prevention and IPC procedures for COVID-19 vaccination
ProjectECHO
1hr 29mins 30secs
12
2021 Jan 26
5
Techincal information
5
Vaccines
2021 Feb 24
161
COVID, Thrombosis, and the Research: Steering into the Storm with Full Sails
NAThrombosisForum
1hr 31mins
51
1
2021 Feb 19
5
Technical information
5
This video addresses the unique cardiovascular (CV) risks and challenges that patients face when recovering from COVID-19, with a particular focus on thrombotic illnesses. The epidemiology, pathophysiology, and prevention of CV complications in COVID-19 was discussed, and the program concluded with a case series exploring key clinical dilemmas in COVID-19-associated thrombosis.
Medicine, symptoms
2021 Feb 24
162
Clot Chronicles: CORONA-VTE—Cardiovascular Findings in COVID-19
NAThrombosisForum
7mins 53secs
126
3
2020 Dec 01
5
Technical information
5
Dr. Gregory Piazza, an Associate Professor of Medicine at Harvard Medical School as well as Staff Physician and Section Head of Vascular Medicine at Brigham and Women's Hospital, discusses CORONA-VTE.
Medicine, symptoms
2021 Feb 24
163
COVID-19 Associated Thrombosis: Who is at risk?
Frederick Southwick
12mins 02secs
93
4
2020 Sep 05
5
Technical information
5
Dr. Anita Rajasekhar, Associate Professor of Medicine at the University of Florida reviews the evidence for an increased predisposition to thrombosis in patients with COVID-19. The majority of events are venous thrombosis, but cases of limb ischemia and stroke, particularly in younger patients have bee reported. There is now agreement that SARS-CoV-2 infection is associated with an increased risk for thrombosis.
Medicine, symptoms
2021 Feb 24
164
COVID 19 and Coagulapathy: Observations, Prognosis, Monitoring and Interventions | Dr. Adam Cuker
Penn Medicine
16mins 05secs
223
3
2020 Oct 03
5
Techincal information
5
Dr. Adam Cuker talks about COVID 19 and Coagulapathy: Observations, Prognosis, Monitoring and Interventions
Medicine, symptoms
2021 Feb 24
165
COVID Vaccine FAQ - Penn Medicine Chief Medical Officer P.J. Brennan Answers Your Questions
Penn Medicine
9mins 13secs
697
12
2021 Feb 12
5
Easy
5
By the time the first COVID-19 Vaccinations were administered in December 2020, the virus had taken the lives of over 300,000 people in the United States. P.J. Brennan, MD, Chief Medical Officer of the University of Pennsylvania Health System answers the most frequently asked questions about the COVID-19 vaccine, and explains why it is important for everyone to get their shot.
Vaccines, Public health
2021 Feb 24
166
Laying the Groundwork for COVID-19 Vaccines: Dr. Drew Weissman and mRNA Technology at Penn Medicine
Penn Medicine
2mins 45secs
5103
51
7
2021 Jan 05
5
Easy
5
Dr. Drew Weissman talks on the development of mRNA technology and how years of research led to the development of COVID-19 vaccines, as well as promising new vaccines for influenza, herpes, HIV, and many other diseases.
Vaccines
2021 Feb 24
167
COVID Vaccine and Pregnancy: A Town Hall Event
Penn Medicine
1hr 05mins
198
3
2021 Feb 02
5
Medium
5
Dr. Elizabeth Howell, Chair of the Department of Obstetrics and Gynecology at Penn Medicine, hosts a town hall focused on the COVID vaccine and pregnancy.
Vaccines
2021 Feb 24
168
Immune Profiling in Patients with COVID-19 | Dr. John Wherry
Penn Medicine
21mins 29secs
451
5
2020 Oct 08
5
Technical information
5
Immune profiliing of Covid-19 patients
Immunology
2021 Feb 25
169
COVID Live Webinar Series: Vaccines, Immunity and T-Cells
Survivor Corps HQ
1hr 04mins
1825
44
2020 Dec 18
5
Technical information
5
Conversation on Vaccines, Immunity and T- Cells
Vaccine
2021 Feb 25
170
Dr. John Wherry: Deep Immune Profiling in SARS-CoV-2 Patients
Human Vaccines Project
1hr
446
11
2020 Sep 11
5
Technical information
5
Global COVID Lab Meeting with Dr. E. John Wherry, Director at the Institute for Immunology and Chair of the Department of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania. His lab recently published a study in Science that uncovered distinct immunotypes in COVID-19 patients, which may have implications for the design of vaccines and therapeutics.
Vaccine
2021 Feb 25
171
Dr. Bette Korber: Spike mutations and recombination in SARS-CoV-2 pandemic viruses
Human Vaccines Project
1hr
1004
17
2020 Jul 13
5
Technical information
5
Dr. Bette Korber's new study suggesting a more transmissible form of SARS-CoV-2 is emerging due to mutations of the Spike (S) protein. Her findings have important implications for SARS-CoV-2 transmission, pathogenesis and immune interventions, and have been widely and sometimes not accurately reported in the press. In this Global COVID Lab Meeting Dr. Bette Korber presents her most important conclusions.
Mutations
2021 Feb 25
172
SARS-CoV-2 Vaccines and Variants
The Rockefeller University
1hr 30secs
2124
40
3
2021 Feb 10
5
Technical information
5
Hope is mounting as COVID-19 vaccines are deployed, but our optimism is tempered by the arrival of new viral strains that are more contagious and possibly vaccine resistant. In this webinar, virologist Paul Bieniasz and President Richard P. Lifton addressed critical questions about SARS-CoV-2 variants, such as "Why are variants suddenly appearing almost simultaneously, but thousands of miles apart?" and "Can lab research predict the types of variants that will emerge?"
Mutations, Vaccines, variants
2021 Feb 25
173
Fighting COVID-19 with Antibody Therapy
The Rockefeller University
1hr 11mins
184
2
2021 Feb 09
5
Technical information
5
In this webinar, Dr. Nussenzweig and President Rick Lifton discussed some of the most pressing questions about COVID-19 research and therapeutic discovery. For example, "What is the status of antibody therapies developed at Rockefeller?" and "Can antibody therapies protect against infection?"
Immnology, therapeutics
2021 Feb 25
174
Racing to Beat COVID-19: The Oxford Vaccine and Other Tales from the UK
The Rockefeller University
1hr 21mins
7327
48
21
2020 Sep 24
5
Technical information
5
Sir John Bell, a renowned biomedical scientist at the University of Oxford, is the leader of a rapidly advancing effort within this unprecedented campaign. Rockefeller University President Rick Lifton and Professor Bell discuss the extraordinary challenges involved in the development and international testing of new vaccines amid a global pandemic, as well as other medical measures needed to bring COVID-19 under control.
Therapeutics
2021 Feb 25
175
Jesse Bloom: "Interpreting the Evolution of SARS-CoV-2"
HHMI Howard Hughes Medical Institute
1hr 14mins
430
2021 Mar 11
5
Technical information
5
Jesse Bloom, an HHMI Investigator and associate professor in the Basic Sciences Division and in the Public Health Sciences Division at Fred Hutchinson Cancer Research Center. He uses computational biology and real-world data to build evolutionary models and examine different scales of viral evolution, from evolution within a single host to evolution on a global scale.
Mutations, Evolution
2021 Mar 14
176
March 1, 2021 ACIP Meeting - SARS-CoV-2 Variants - Consideration for vaccine
Centers for Disease Control and Prevention (CDC)
47mins
1061
16
5
2021 Mar 06
5
Technical information
5
Dr.Heather Scobie, CDR, talks about the SARS-CoV-2 variants and the efficacy of various vaccines on the variant strains
Variants, Vaccine
2021 Mar 14
177
WHO's Science in 5 on COVID-19: Evolution of the SARS-CoV-2 virus
World Health Organization (WHO)
4mins 31secs
4549
62
23
2021 Mar 05
5
Easy
5
WHO's Dr. Maria Van Kerkhove, talks about the latest information on the SARS-CoV-2 virus variants.
Variants, Virus evolution
2021 Mar 14
178
Virus closely related to SARS-CoV-2 found in horseshoe bats in Southeast Asia
CGTN
3mins 41secs
12851
318
22
2021 Feb 28
5
Easy
5
While the origin of the coronavirus has yet to be determined, researchers in Cambodia and Thailand have found a virus that's closely related to it in horseshoe bats. They're the first known relatives of the coronavirus to be found outside China.
Virus evolution
2021 Mar 14
179
Emergence and spread of a new SARS-CoV-2 Variant (501Y.V2) in South Afric
DiscoverySA
1hr 13mins
128
1
2021 Mar 05
5
Technical information
5
In this webinar, Professor Tulio de Oliveira and Doctor Richard Lessells, share about the South African Variant of SARS CoV-2, with meaningful insights on how it spread, the impact on the pandemic response as well as the clinical implications
Variants
2021 Mar 14
180
Procalcitonin's Role in Antibiotic Stewardship & SARS-CoV-2 Infection, Secondary Bacterial Infection
SCCM
1 hr
91
5
2021 Mar 13
4
Technical information
5
Dr.Michael Mansour and Dr.Natalie J. Atallah talks about the current approved clinical uses demonstrating PCT (Procalcitonin) utility in helping to differentiate bacterial versus viral infection in LRTI (lower respiratory track infections) and provide aid in antibiotic decision making
Medicine, symptoms
2021 Mar 14
181
The Science behind cPass™
Duke-NUS
2mins 25secs
40
1
2021 Mar 12
4
Technical information
5
This video describes the science behind the SARS-CoV-2 antibody detection kit
testing / diagnosis
2021 Mar 14
182
Flowflex SARS-CoV-2 Antigen Rapid Test (Self-testing)
ACON Laboratories, Inc
2mins 25secs
19
1
2021 Mar 13
4
Easy
5
This video describes a self-testing SARS-CoV-2 Antigen Rapid Test.
testing / diagnosis
2021 Mar 14
183
Coronavirus Variants
JAMA Network
34mins 41secs
29977
705
34
2021 Mar 05
5
Technical information
5
Dr.John Moore, Professor of Virology, approaches for the optimal use of different COVID-19 vaccines . Issues of viral variants and viral efficacy.
Variants, vaccines
2021 Mar 14
184
Animation of SARS-CoV-2 entry into human host-cell.
ThornLab
1min 54 secs
443
19
20201 Mar 09
5
Technical information
5
Animation of SARS-CoV-2 entry into human cell
Molecular biology
2021 Mar 14
185
Ravindra Gupta: "SARS-CoV-2 evolution during treatment of chronic infection"
HHMI Howard Hughes Medical Institute
55mins 20secs
401
2021 Feb 26
5
Technical information
5
Ravi Gupta, Professor of Clinical Microbiology talks about Neutralising antibodies and SARS-CoV-2 evolution
Microbiology
2021 Mar 14
186
Michel Nussenzweig: "Fighting COVID-19 with Neutralizing Antibodies"
HHMI Howard Hughes Medical Institute
44mins 11secs
457
2021 Jan 18
5
Technical information
5
Dr.Michel Nussenzweig, professor of molecular immunology, talks of neutralising antibodies in combacting SARS-CoV-2
Immunology
2021 Mar 14
187
What do SARS-CoV-2 Genomes Tell us About the Pandemic Spread? (CCDD ID Epi Seminar Series)
Center for Communicable Disease Dynamics
58mins 38secs
97
3
2021 Mar 12
5
Technical information
5
Dr. Tanja Stadler, Associate Professor at the Department of Biosystems Science and Engineering of the Swiss Federal Institute of Technology (ETH Zürich) in Basel, as well as a member of the Swiss National COVID-19 Science Task Force, talks about extracting information from SARS-CoV-2 genomes and about the pandeminc spread of Covid-19.
Bioinformatics
2021 Mar 16
188
COVID-19 in Brazil (CCDD ID Epi Seminar Series)
Center for Communicable Disease Dynamics
56mins
51
1
2021 Mar 05
5
Technical information
5
Dr. Marcia Castro, Andelot Professor of Demography and Chair of the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health, as well as co-director of the Brazil Studies Program of the David Rockefeller Center for Latin American Studies (DRCLAS). Her research focuses on the development and use of multidisciplinary approaches to identify the determinants of infectious disease transmission in different ecological settings to inform control policies.
Public health
2021 Mar 16
189
Mayo Clinic Insights: What is a COVID-19 variant strain
Mayo Clinic
3mins 21secs
406799
1.3K
1.2K
2021 Mar 02
5
Easy
5
Dr. Binnicker provides information on the current COVID-19 variants and how we can help stop the spread of new strains in our communities.
Variants
2021 Mar 16
190
How the Johnson & Johnson SARS-CoV-2 vaccine works
Color
2mins 35secs
2759
31
2
2021 Feb 28
5
Easy
5
chief science officer, Alicia Zhou, Ph.D., on how the Johnson & Johnson vaccine works.
Vaccines
2021 Mar 16
191
Why is the Johnson & Johnson vaccine just as effective as the Moderna and Pfizer vaccines?
University Hospitals
1mins 05secs
8425
70
3
2021 Mar 04
5
Easy
5
Keith Armitage, MD, infectious disease physician and Medical Director, UH Roe Green Center for Travel Medicine & Global Health, discusses the important efficacy similarities between the Johnson & Johnson vaccine and the Moderna/Pfizer vaccines.
Vaccines
2021 Mar 16
192
Mayo Clinic Insights: What you should know about the Johnson & Johnson COVID-19 vaccine
Mayo Clinic
3mins 15secs
36257
535
55
2021 Mar 12
5
Easy
5
Dr. Swift discusses what you need to know about the new Johnson & Johnson COVID-19 vaccine.
Vaccines
2021 Mar 16
193
The COVID-19 Vaccines from Johnson & Johnson and AstraZeneca: What's in Them and How Do They Work?
ARUP Laboratories
11mins 09secs
9541
132
7
2021 Mar 09
5
Easy
5
The composition and delivery mechanism for the new classes of COVID-19 vaccines based on adenovirus from Johnson & Johnson and AstraZeneca with Dr. Jonathan Genzen, COO of ARUP Laboratories and an Associate Professor at the University of Utah School of Medicine.
Vaccines
2021 Mar 16
194
Johnson & Johnson COVID-19 Vaccine: Effectiveness, Side Effects and Differences Between Vaccines
UC Davis Health
2mins 44secs
384779
1.8K
945
2021 Mar 03
5
Easy
5
Dr. Dean Blumberg, Chief of Pediatric Infectious Diseases at UC Davis Children's Hospital, explains how the new Johnson and Johnson COVID-19 vaccine works and answers common questions, including why it's different from other coronavirus vaccines, how side effects compare to Pfizer and Moderna vaccines
Vaccines
2021 Mar 16
195
What The COVID Vaccine Does To Your Body
AsapSCIENCE
5mins 22secs
4207118
88K
19K
2020 Dec 08
5
Easy
5
Is the coronavirus vaccine safe? Now that the first COVID19 vaccine from Pfizer is being released, how do mRNA vaccines work?
Vaccines
2021 Mar 16
196
Coronavirus Update 121: Johnson and Johnson Vaccine - Efficacy and Safety vs. Pfizer & Moderna
MedCram - Medical Lectures Explained CLEARLY
11mins 24secs
390611
7.1K
373
2021 Feb 05
5
Easy
5
Professor Roger Seheult, MD explains the Johnson and Johnson / Janssen Pharmaceuticals vaccine candidate for COVID 19. Dr. Seheult illustrates how the Johnson & Johnson adenovirus vaccine works, the efficacy/safety (based on preliminary data), and how the vaccine compares to the Moderna vaccine and the Pfizer BioNTech vaccine.
Vaccines
2021 Mar 16
197
Johnson and Johnson Vaccine What You Need to Know
Medicine with Dr. Moran
8mins 16secs
162726
2.6K
104
2021 Feb 12
5
Easy
5
Dr. Moran compares the Pfizer and Moderna vaccines to the new Johnson and Johnson and Janssen pharmaceuticals COVID-19 vaccine. The Johnson & Johnson vaccine was tested against the new COVID-19 variants in Brazil and South Africa. Dr. Moran answers whether you should opt for the Pfizer, Moderna, AstraZeneca or Johnson and Johnson vaccine. The costs of the Pfizer, modernity, AstraZeneca and Johnson & Johnson vaccines are compared.
Vaccines
2021 Mar 16
198
All Types of COVID-19 Vaccines, How They Work, Animation.
Alila Medical Media
5mins 55secs
33989
665
17
2021 Jan 27
5
Easy
5
How it works. mRNA vaccine (Pfizer, Moderna), DNA & Viral vector vaccines (Johnson & Johnson (J&J, JNJ), Oxford-AstraZeneca, Inovio, Sputnik V); protein/peptide vaccine (Novavax, EpiVacCorona), conventional inactivated (CoronaVac of Sinovac, Covaxin). Mechanism of each type of coronavirus vaccines explained. Vaccine-induced immune response as compared to natural immunity.
Vaccines
2021 Mar 16
199
Johnson & Johnson COVID-19 Vaccine Q&A with Dr. Brahm Segal
Roswell Park Comprehensive Cancer Center
13mins 13secs
4445
54
4
2021 Mar 06
5
Easy
5
Dr. Brahm Segal discusses the different types of COVID-19 vaccines.
Vaccines
2021 Mar 16
200
Johnson & Johnson COVID-19 Vaccine
Mount Sinai Health System
16mins 47secs
328735
1.3K
2.8K
2021 Feb 12
5
Techincal information
5
Dr. Dana Mazo discusses the Johnson & Johnson COVID-19 vaccine.
Vaccines
2021 Mar 16
201
Comparing Johnson & Johnson Janssen Covid-19 Vaccine to Pfizer and Moderna
Medical College of Wisconsin
2mins 13secs
13506
105
20
2021 Mar 09
5
Easy
5
MCW associate professor Dr. Ben Weston shares his knowledge on the benefits, development technology, and the safety and efficacy of the Johnson & Johnson/Janssen COVID-19 vaccine.
Vaccines
2021 Mar 16
202
The Pathophysiology of SARS CoV-2 - Angela Campbell & Ellen Hillegass
MedBridge
2mins 22secs
95
1
2021 Feb 25
5
Easy
5
Pathophysiology of SARS_CoV-2
Pathophysiology
2021 Mar 16
203
Immunity Against SARS-CoV-2 and COVID-19 Vaccines
Icahn School of Medicine
1hr 01min
66
2
1
2021 Mar 16
5
Technical information
5
A Mount Sinai Morningside and Mount Sinai West Department of Medicine Grand Rounds presented by Florian Krammer, PhD, Professor of Microbiology
Vaccines, Immunology
2021 Mar 16
204
Notable variants of SARS-CoV-2 that emerged in late 2020
What the Science
29secs
33
6
2021 Mar 13
5
Easy
5
Variants of SARS-CoV-2
Variants
2021 Mar 16
205
B.1.526 a new SARS CoV-2 Variant in New York
What the Science
1min 24secs
543
10
2021 Feb 27
5
Easy
5
A new variant of the coronavirus, known as B.1.526, is spreading across New York City causing concerns among researchers regarding how it might affect the vaccination process.Research shows that this New York variant shares characteristics with the variants B.1.351 and P.1, identified in South Africa and Brazil respectively.
Variants
2021 Mar 16
206
Ryan Interviews Health care Expert About Coronavirus. Let's Learn How we can help each other.
Ryan's World
14min 49secs
4884141
17k
2.2k
2020 Apr 17
5
Easy
4
General
2021 Mar 16